Literature DB >> 21450370

Truncated tau and Aβ cooperatively impair mitochondria in primary neurons.

Rodrigo A Quintanilla1, Philip J Dolan, Youngnam N Jin, Gail V W Johnson.   

Abstract

Mitochondrial dysfunction is likely a significant contributing factor to Alzheimer disease pathogenesis, and both amyloid peptide (Aβ) and pathological forms of tau may contribute to this impairment. Cleavage of tau at Asp421 occurs early in Alzheimer disease, and Asp421-cleaved tau likely negatively impacts neuronal function. Previously we showed that expression of Asp421-cleaved tau in a neuronal cell model resulted in mitochondrial impairment. To extend these findings we expressed either full length tau or Asp421-cleaved tau (truncated tau) in primary cortical neurons and measured different aspects of mitochondrial function with or without the addition of sublethal concentrations of Aβ. The expression of truncated tau alone induced significant mitochondrial fragmentation in neurons. When truncated tau expression was combined with Aβ at sublethal concentrations, increases in the stationary mitochondrial population and the levels of oxidative stress in cortical neurons were observed. Truncated tau expression also enhanced Aβ-induced mitochondrial potential loss in primary neurons. These new findings show that Asp421-cleaved tau and Aβ cooperate to impair mitochondria, which likely contributes to the neuronal dysfunction in Alzheimer disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450370      PMCID: PMC3140623          DOI: 10.1016/j.neurobiolaging.2011.02.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  36 in total

1.  Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model.

Authors:  Pavan K Krishnamurthy; Gail V W Johnson
Journal:  J Biol Chem       Date:  2003-12-02       Impact factor: 5.157

2.  Axonal mitochondrial transport and potential are correlated.

Authors:  Kyle E Miller; Michael P Sheetz
Journal:  J Cell Sci       Date:  2004-05-18       Impact factor: 5.285

3.  Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.

Authors:  K S Kosik; C L Joachim; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Proapoptotic effects of tau cleavage product generated by caspase-3.

Authors:  C W Chung; Y H Song; I K Kim; W J Yoon; B R Ryu; D G Jo; H N Woo; Y K Kwon; H H Kim; B J Gwag; I H Mook-Jung; Y K Jung
Journal:  Neurobiol Dis       Date:  2001-02       Impact factor: 5.996

5.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; M Quinlan; H M Wisniewski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies.

Authors:  Tomás L Falzone; Shermali Gunawardena; David McCleary; Gerald F Reis; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2010-09-03       Impact factor: 6.150

Review 7.  The role of the metabolic lesion in Alzheimer's disease.

Authors:  John P Blass; Gary E Gibson; Siegfried Hoyer
Journal:  J Alzheimers Dis       Date:  2002-06       Impact factor: 4.472

8.  Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.

Authors:  T Chris Gamblin; Feng Chen; Angara Zambrano; Aida Abraha; Sarita Lagalwar; Angela L Guillozet; Meiling Lu; Yifan Fu; Francisco Garcia-Sierra; Nichole LaPointe; Richard Miller; Robert W Berry; Lester I Binder; Vincent L Cryns
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-29       Impact factor: 11.205

9.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

10.  Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses.

Authors:  E-M Mandelkow; K Stamer; R Vogel; E Thies; E Mandelkow
Journal:  Neurobiol Aging       Date:  2003-12       Impact factor: 4.673

View more
  54 in total

1.  Mechanisms of tau and Aβ-induced excitotoxicity.

Authors:  Susanne P Pallo; John DiMaio; Alexis Cook; Bradley Nilsson; Gail V W Johnson
Journal:  Brain Res       Date:  2015-12-28       Impact factor: 3.252

2.  Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease.

Authors:  María José Pérez; Katiana Vergara-Pulgar; Claudia Jara; Fabian Cabezas-Opazo; Rodrigo A Quintanilla
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

Review 3.  The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Authors:  Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

Review 4.  Inhibitors of mitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction.

Authors:  P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 5.  In vivo functions of Drp1: lessons learned from yeast genetics and mouse knockouts.

Authors:  Hiromi Sesaki; Yoshihiro Adachi; Yusuke Kageyama; Kie Itoh; Miho Iijima
Journal:  Biochim Biophys Acta       Date:  2013-12-08

Review 6.  A Mitocentric View of Alzheimer's Disease.

Authors:  Hao Hu; Chen-Chen Tan; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-10-01       Impact factor: 5.590

7.  Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease.

Authors:  Bhumsoo Kim; Carey Backus; Sangsu Oh; Eva L Feldman
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  DL0410, a novel dual cholinesterase inhibitor, protects mouse brains against Aβ-induced neuronal damage via the Akt/JNK signaling pathway.

Authors:  Dan Zhou; Wei Zhou; Jun-Ke Song; Zhang-Ying Feng; Ran-Yao Yang; Song Wu; Lin Wang; Ai-Lin Liu; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2016-08-08       Impact factor: 6.150

9.  A synergic role of caspase-6 and caspase-3 in Tau truncation at D421 induced by H2O 2.

Authors:  Hong Zhao; Wenjuan Zhao; Kenghoe Lok; Zejian Wang; Ming Yin
Journal:  Cell Mol Neurobiol       Date:  2013-12-21       Impact factor: 5.046

10.  Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.

Authors:  Michael H Yan; Xinglong Wang; Xiongwei Zhu
Journal:  Free Radic Biol Med       Date:  2012-11-29       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.